Legal approval comes first
Foreign donor and recipient cases require prior Authorization Committee approval under THOTA and official relationship evidence.
India renal transplant cost guide
A living-donor kidney transplant involves two patients and a regulated approval process. Cost depends on recipient fitness, donor independence and anatomy, relationship evidence, compatibility, dialysis, desensitization, two operations, ICU, rejection or infection, and lifelong immunosuppression. Buying or selling an organ is illegal.
How much does kidney transplant cost in India?
A standard living-related kidney transplant in India may require about INR 8,00,000-14,00,000 (USD 8,300-14,500) for the hospital pathway. ABO-incompatible, medically complex, prolonged-dialysis, rejection, vascular, infection, or ICU pathways may reach INR 14,00,000-25,00,000+ (USD 14,500-26,000+). Donor evaluation, legal documents, medicines, accommodation, and long-term follow-up must be confirmed separately.
Rounded USD figures use about INR 96.22 per USD from the RBI display on July 15, 2026. Hospitals bill in INR; medicine, dialysis, blood products, complications, and exchange movement can change the total.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-18
Clinical review: Virello Health Clinical Review Team · Editorial review: Virello Health Medical Travel Editorial Team
Billing context: INR and USD
Foreign donor and recipient cases require prior Authorization Committee approval under THOTA and official relationship evidence.
Donor medical, surgical, psychosocial, consent, recovery, complication, and long-term follow-up needs must be protected.
Recipient and donor have separate admissions; graft function, dialysis, infection and medicine levels determine discharge.
Immunosuppressants, drug levels, blood tests, nephrology visits, infection prevention, and graft surveillance continue after travel.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | INR | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Compatible living-related pathway | INR 8,00,000-14,00,000 | USD 8,300-14,500 | Stable recipient and independently suitable adult near-relative donor with compatible testing and authorization. | Recipient and donor surgery, standard admission, routine immunology and early follow-up assumptions require written confirmation. |
| Higher-complexity living-donor pathway | INR 12,00,000-20,00,000 | USD 12,500-20,800 | ABO or immune complexity, obesity, vascular anatomy, prior transplant, dialysis instability, or greater cardiac and infection risk. | May add plasmapheresis, immunoglobulin, dialysis, specialist care, longer stay, blood, or advanced surgery. |
| Complication or prolonged-recovery pathway | INR 16,00,000-25,00,000+ | USD 16,600-26,000+ | Delayed graft function, rejection, infection, bleeding, vascular or urinary complication, ICU, biopsy, or readmission. | Use as a contingency range; prolonged dialysis, high-cost antimicrobials, and re-operation are usually outside base packages. |
Usually included
Kidney failure cause, compatibility, cardiac and infection fitness, imaging, dialysis and surgical review.
List every included test.
Medical, kidney, anatomy, infection, psychosocial, coercion-free consent, and surgical assessment.
Donor welfare cannot be bundled away.
Donor nephrectomy and recipient transplant with two teams, anesthesia, theatre, standard consumables, and room assumptions.
Robotic donor surgery may be separate.
ICU or monitored care, labs, ultrasound, immunosuppression, infection prophylaxis, and stated follow-up.
Confirm drug and day limits.
Confirm separately
Relationship certification, translations, notarization, travel, visa, and committee-related document work.
Approval can never be purchased or guaranteed.
Plasmapheresis, immunoglobulin, immune medicines, repeated antibody testing, and extra admission.
Obtain a protocol-specific quote.
Hemodialysis, catheter, fistula care, admission, transfusion, or infection treatment before surgery.
Plan delays safely.
Rejection biopsy and therapy, dialysis, ICU, re-operation, high-cost infection care, and post-return immunosuppression.
Keep a substantial reserve.
Candidate context
The transplant team determines recipient benefit and operative fitness while a separate donor pathway protects the donor. Blood group, crossmatch, HLA and antibodies, kidney and vascular anatomy, infection, cancer screening, cardiac risk, adherence, relationship evidence, psychosocial findings, and long-term follow-up all affect eligibility and timing.
Cause of kidney failure, dialysis status, cardiac and vascular risk, infection, malignancy history, and adherence are assessed.
A healthy adult donor needs acceptable kidney function and anatomy, low future risk, free consent, and independent follow-up.
Blood group, HLA, crossmatch, donor-specific antibodies, and previous transfusion, pregnancy, or transplant history guide immune planning.
Relationship and identity documents must satisfy the hospital and Authorization Committee; commercial donation is prohibited.
Hemodialysis or peritoneal dialysis can maintain treatment while evaluation, donor approval, or deceased-donor options are considered.
A medically suitable near relative may offer a scheduled pathway after independent consent and legal approval.
Paired exchange or selected ABO-incompatible treatment may be discussed under current legal and clinical rules.
Eligibility, registration, allocation, waiting time, and foreign-national rules must be confirmed through the registered center and NOTTO system.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
Standard donor and recipient evaluation with negative crossmatch and approved relationship.
Still requires full donor safety review.
May need antibody testing, plasmapheresis, immunoglobulin, and intensified immune management.
Infection and rejection costs are higher.
Incompatible donor-recipient pairs may exchange donors under applicable rules and synchronized planning.
Legal and operational complexity increases.
Depends on registration, allocation, organ availability, urgency, and rapid admission rather than a scheduled package.
Foreign-national access requires current verification.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Delhi NCR and Gurugram | INR 9,00,000-25,00,000+ | USD 9,400-26,000+ | Multiple registered transplant centers support complex immunology, surgery, ICU, dialysis, and international documentation. | Compare committee pathway and local stay. |
| Mumbai | INR 9,00,000-25,00,000+ | USD 9,400-26,000+ | Broad nephrology, transplant surgery, dialysis, vascular, and critical-care access. | Public and private timelines differ. |
| Chennai | INR 8,50,000-22,00,000+ | USD 8,800-22,900+ | Established living and deceased donor systems at selected registered hospitals. | Verify state and foreign-national process. |
| Hyderabad | INR 8,00,000-21,00,000+ | USD 8,300-21,800+ | Selected high-volume programs offer transplant nephrology, surgery, immunology, dialysis and ICU. | Confirm donor technique and complication terms. |
| Bengaluru | INR 8,50,000-22,00,000+ | USD 8,800-22,900+ | Tertiary programs support complex recipient fitness and long-term transplant care. | Check immunology turnaround and medicine access. |
| Kolkata | INR 8,00,000-20,00,000+ | USD 8,300-20,800+ | Selected registered centers serve eastern and neighboring origins. | Confirm committee schedule and donor lodging. |
| Ahmedabad | INR 7,50,000-19,00,000+ | USD 7,800-19,700+ | Selected multispecialty programs provide renal transplant and ICU support. | Verify complex desensitization capability. |
| Pune | INR 8,00,000-20,00,000+ | USD 8,300-20,800+ | Registered tertiary hospitals manage selected living-donor pathways. | Ask where major complications are handled. |
| Kochi | INR 7,50,000-19,00,000+ | USD 7,800-19,700+ | Established Kerala programs support recipient, donor, dialysis and follow-up care. | Regional access may ease long monitoring. |
| Indore, Nagpur or Vizag | INR 7,00,000-17,00,000+ | USD 7,300-17,700+ | Only registered hospitals with transplant nephrology, surgery, immunology, dialysis, blood bank and ICU should be considered. | Complex immune or vascular cases may need a metro. |
Estimate variables
Repeated compatibility, anatomy, organ, infection, cancer, cardiac, and psychosocial tests affect pre-surgery cost.
Track both patients separately.
Nationality, relationship, residence, translations, embassy certificate, committee review, and resubmission affect timing and lodging.
No facilitator can guarantee approval.
Antibodies, ABO mismatch, previous transplant, transfusion, and pregnancy can add desensitization and monitoring.
Request protocol details.
Anatomy, open, laparoscopic or robotic donor approach, vascular reconstruction, obesity, and prior surgery change scope.
Name the technique assumptions.
Delayed function, dialysis, biopsy, immune therapy, thrombosis, leak, or obstruction can extend admission.
Base packages often exclude these.
Drug choice, levels, infection prophylaxis, laboratory work, and brand availability shape ongoing cost.
Secure home supply before travel.
Medical cost breakdown
Blood, urine, dialysis, cardiac, vascular, imaging, infection, cancer, and anesthesia assessment.
Update tests near surgery.
Kidney function, urine, metabolic risk, CT angiography, infection, cancer screening, and independent psychosocial review.
Donor may be declined for safety.
Blood group, HLA, crossmatch, antibodies, and selected repeat or virtual tests.
Timing matters after transfusion.
Identity, relationship, marriage or birth evidence, embassy certificate, translations, photographs, and committee forms.
Use current hospital and NOTTO lists.
Independent team, anesthesia, nephrectomy, room, pain and complication care.
Donor follow-up should be explicit.
Transplant surgery, anesthesia, theatre, vascular and urinary work, standard consumables and monitoring.
Unusual reconstruction costs extra.
Urine, ultrasound, blood tests, drug levels, immunosuppression, dialysis, and infection prevention.
Define day limits.
Medicine supply, warning signs, laboratory schedule, hydration, wound, donor and recipient appointments.
Keep separate summaries.
Frequent creatinine, electrolytes, blood counts, levels, glucose, infection and urine checks.
Frequency reduces over time.
Lifelong anti-rejection treatment plus time-limited infection prevention.
Never interrupt supply.
Wound, blood pressure, kidney function, pain, activity, and long-term primary care.
Donor care continues after travel.
Rapid local biopsy, admission, antimicrobial and specialist care must be available.
Delayed treatment threatens the graft.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Separate flexible flights, visas, ground transfers, and changed return dates.
Donor and recipient recover differently.
Embassy certification, translations, notarization, courier and committee visits.
Budget time, not only fees.
Dialysis access, clean accommodation, food, transport and proximity for both patients.
Approval delays can extend stay.
Initial drug supply, laboratory, nephrology, donor review and emergency access.
Confirm generic and brand continuity.
Extra dialysis, rejection, infection, biopsy, readmission, ICU, re-operation, or flight changes.
Keep outside the quoted package.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Organ transplantation is regulated under THOTA and rules; organ purchase and sale are illegal.
When donor or recipient is foreign, Authorization Committee approval is required before organ removal and transplant.
NOTTO states transplant treatment requires medical visas for both foreign recipient and living donor; verify current official rules.
Foreign near-relative cases require embassy-issued relationship certification and the committee’s document review.
An Indian living donor may donate to a foreign recipient only when the person is a near relative under applicable rules.
Hospital selection
Verify current authorization for kidney transplantation and the applicable hospital or state committee.
Registration is mandatory.
Check donor advocate, psychosocial review, coercion screening, medical exclusion, consent, complication cover and follow-up.
Donor safety comes before scheduling.
Confirm HLA, crossmatch, antibody, desensitization, biopsy and drug-level pathways.
Important for sensitized recipients.
Require 24-hour dialysis, interventional radiology, vascular surgery, blood bank, microbiology and ICU.
Delayed graft function needs immediate support.
Request the current checklist, translation rules, committee route, expected review process and refusal policy.
Approval cannot be promised.
Separate donor, recipient, immune, dialysis, surgery, room, drugs, follow-up, complications and legal exclusions.
Do not compare one headline total.
Treating team
Assesses recipient, dialysis, immune risk, medicines, graft monitoring and long-term care.
Plans vessels, urinary connection, prior surgery, obesity and complication response.
Protect donor selection, anatomy, informed consent, operation, recovery and surveillance.
Manages HLA, crossmatch, antibodies, drug levels and graft biopsy interpretation.
Support delayed function, sepsis, bleeding, rejection and organ complications.
Hospital comparison guides
Use these report-led guides to compare programme capability, clinical support, city fit, verification questions, recovery planning, and continuity after returning home.
Treatment timeline
Clinical records, relationship, blood group and major contraindications are reviewed.
Both patients complete independent medical, surgical, compatibility and psychosocial assessment.
Identity, relationship, embassy and committee documents are submitted and approval awaited.
Crossmatch, infection, dialysis, medicines and anesthesia readiness are reconfirmed.
Kidney removal and transplantation proceed with separate safety teams.
Kidney function, dialysis need, wound, infection, drug levels and donor function guide discharge.
Home nephrology continues medicines, tests, infection prevention, rejection response and donor surveillance.
Risks and edge cases
Medical, psychosocial, relationship or legal findings can stop the pathway.
Clarify refund and alternative-care terms.
The kidney may work slowly and require dialysis, longer admission and repeated imaging.
Ask how dialysis is billed.
Immune injury can require biopsy, steroids, antibody treatment, plasmapheresis or other therapy.
No transplant is rejection-proof.
Immunosuppression increases bacterial, viral and fungal risk during admission and after return.
Fever needs urgent care.
Thrombosis, bleeding, leak, obstruction or collection may require radiology or surgery.
Verify same-campus rescue.
Supply, vomiting, interaction or dose error can endanger the graft.
Carry extra medicines and written generic names.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Legal pathway | THOTA, Authorization Committee and foreign near-relative documentation apply. | Living-donor relationship and foreign-patient rules require current center verification. | Donation and foreign-recipient eligibility must be confirmed under Thai rules. | Never choose a destination promising to bypass legal review. |
| Hospital cost | Compatible living-donor planning often begins near USD 8,300, excluding lifetime care. | Private quotes may use EUR or USD with donor workup separated. | Private packages may carry higher hospital and lodging costs. | Compare both patients, immune pathway and complications. |
| Complex capability | Several metros provide desensitization, swap, vascular, dialysis and ICU pathways. | Complex care is concentrated in specialist programs. | Major centers provide selected advanced pathways. | Match immune and surgical risk to the center. |
| Long-term continuity | Medicine options are broad, but home supply and drug-level testing must be secured. | Confirm translated prescriptions and home availability. | Check product continuity and laboratory access. | Lifelong care outweighs short-term package savings. |
Decision guidance
A lawful donor-recipient pair, safe travel, registered center, complete evaluation, transparent approval and reliable lifelong home care are present.
The recipient is sensitized, previously transplanted, vascularly complex, unstable on dialysis, or likely to need intensive support.
The compatible pathway is straightforward and the registered center has strong immunology, dialysis, blood bank, ICU and donor follow-up.
The patient is unstable, infection or cardiac risk is uncontrolled, documentation is not lawful, or medicine and emergency continuity cannot be guaranteed.
Reports for review
Send recipient kidney history, dialysis and access records, blood group, transfusions, pregnancies and previous transplant, donor relationship and identity evidence, both patients’ medical histories, compatibility tests, CT anatomy, infection and cancer screening, cardiac workup, medicines, and every legal document already obtained.
Upload medical reportsThese define benefit, immune risk and surgical safety.
Cause, biopsy, dialysis modality, access, urine output, admissions and infections.
Blood group, HLA, crossmatch, donor-specific antibodies and sensitizing events.
ECG, echo, coronary review when indicated, vessel imaging and anesthesia findings.
Current viral, bacterial, tuberculosis and age-appropriate malignancy tests.
These protect donor welfare and authorization integrity.
Kidney function, urine, metabolic risk, CT angiography and surgical opinion.
Medical, psychosocial, consent, coercion, future risk and follow-up documents.
Passports, birth or marriage records, photographs and embassy certificate where required.
Use current NOTTO and hospital forms, translations, submissions and decisions.
Common questions
Potentially, but both must satisfy clinical suitability, medical-visa requirements, relationship evidence, THOTA rules and prior Authorization Committee approval. The hospital must confirm the current pathway.
No. Buying or selling organs is illegal. Donor consent must be voluntary and free from coercion or commercial dealing.
Not always. Request a separate donor test, consultation, imaging, operation, room, complication and follow-up budget.
The committee verifies identities, relationship, consent and legality. Missing, inconsistent or untranslated evidence can require clarification and no approval is guaranteed.
Recipients generally need lifelong immunosuppression, with dose and regimen adjusted by the transplant team. Supply and monitoring must be arranged before return.
Only a registered center with donor safeguards, transplant nephrology and surgery, immunology, dialysis, blood bank, ICU and legal support should be considered.
Delayed graft function may require dialysis, imaging, biopsy, longer admission and medicine changes. Ask how each item is billed.
Their timelines differ and depend on approval, surgery, graft function, wound, medicine levels and complications. Both teams must provide travel clearance.
Usually only routine care within limits. Rejection, infection, dialysis, ICU, biopsy, intervention and re-operation should be priced as exclusions or contingencies.
No. Virello does not source donors or influence authorization. It can help organize lawful records and compare transparent hospital assumptions.
Review and sources
Virello combined current NOTTO legal and donor criteria, existing Indian hospital benchmarks, and RBI currency context. The range separates compatible, immune-complex, and complicated pathways because donor evaluation, authorization, dialysis, desensitization, graft function, rejection, infection and lifelong medicines cannot be represented by one surgical price.
This guide is educational and does not determine recipient or donor suitability, legal approval, organ allocation or outcome. Chest pain, severe breathlessness, fever, confusion, reduced urine, bleeding, dialysis instability or rapid deterioration requires urgent local care.
Ministry of Health and Family Welfare / NOTTO · Accessed 2026-07-18
Supports: THOTA, medical visa, adult donor, near-relative, foreign-national approval and Indian-donor restrictions.
NOTTO · Accessed 2026-07-18
Supports: Donor compatibility, kidney function, infection, anatomy, psychosocial assessment and follow-up.
NOTTO · Accessed 2026-07-18
Supports: Current donor, recipient, hospital, Authorization Committee and foreign relationship forms.
NOTTO · Accessed 2026-07-18
Supports: Official legal framework and current amendment listings.
Reserve Bank of India · Accessed 2026-07-18
Supports: INR to USD planning conversion.
Bureau of Immigration, Government of India · Accessed 2026-07-18
Supports: Official visa application guidance.
Related planning
Compare donor review, regulatory checks, hospital scope, and post-transplant continuity in Turkey.
Browse completed country-cost guidance.
Review eligibility, donor workup, surgery, medicines and recovery.
Compare another regulated living-donor pathway.
Assess registered programs and critical backup.
Compare renal transplant-specific capability.
Understand recipient and donor surgical expertise.
Plan dialysis, immune and lifelong graft care.
Prepare official patient and donor travel documents.
Organize both patients’ clinical and legal records.
Transfer medicines, laboratory and emergency responsibilities.
Questions about an estimate? Email support@virellohealth.com.